KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Times Interest Earned: 2009-2025

Historic Times Interest Earned for Biomarin Pharmaceutical (BMRN) over the last 14 years, with Sep 2025 value amounting to -$18.10.

  • Biomarin Pharmaceutical's Times Interest Earned fell 147.18% to -$18.10 in Q3 2025 from the same period last year, while for Sep 2025 it was $57.53, marking a year-over-year increase of 166.02%. This contributed to the annual value of $38.23 for FY2024, which is 256.73% up from last year.
  • Latest data reveals that Biomarin Pharmaceutical reported Times Interest Earned of -$18.10 as of Q3 2025, which was down 117.52% from $103.35 recorded in Q2 2025.
  • Over the past 5 years, Biomarin Pharmaceutical's Times Interest Earned peaked at $103.35 during Q2 2025, and registered a low of -$18.10 during Q3 2025.
  • Its 3-year average for Times Interest Earned is $33.63, with a median of $24.94 in 2024.
  • In the last 5 years, Biomarin Pharmaceutical's Times Interest Earned surged by 1,663.71% in 2023 and then crashed by 147.18% in 2025.
  • Over the past 5 years, Biomarin Pharmaceutical's Times Interest Earned (Quarterly) stood at -$17.13 in 2021, then soared by 78.93% to -$3.61 in 2022, then skyrocketed by 223.94% to $4.47 in 2023, then surged by 1,300.13% to $62.63 in 2024, then crashed by 147.18% to -$18.10 in 2025.
  • Its Times Interest Earned stands at -$18.10 for Q3 2025, versus $103.35 for Q2 2025 and $78.20 for Q1 2025.